DLK Investment Management LLC Sells 67,219 Shares of Kenvue Inc. $KVUE

DLK Investment Management LLC lessened its stake in shares of Kenvue Inc. (NYSE:KVUE) by 39.6% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 102,727 shares of the company’s stock after selling 67,219 shares during the quarter. DLK Investment Management LLC’s holdings in Kenvue were worth $1,772,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Cornerstone Planning Group LLC boosted its holdings in shares of Kenvue by 705.2% during the third quarter. Cornerstone Planning Group LLC now owns 1,554 shares of the company’s stock worth $25,000 after acquiring an additional 1,361 shares during the period. NBT Bank N A NY increased its stake in shares of Kenvue by 180.3% during the third quarter. NBT Bank N A NY now owns 1,564 shares of the company’s stock worth $25,000 after purchasing an additional 1,006 shares during the period. Salomon & Ludwin LLC bought a new position in shares of Kenvue during the third quarter worth approximately $25,000. Golden State Wealth Management LLC lifted its holdings in Kenvue by 150.1% during the 3rd quarter. Golden State Wealth Management LLC now owns 1,983 shares of the company’s stock worth $32,000 after purchasing an additional 1,190 shares during the last quarter. Finally, Trust Co. of Vermont lifted its holdings in Kenvue by 50.9% during the 3rd quarter. Trust Co. of Vermont now owns 2,385 shares of the company’s stock worth $39,000 after purchasing an additional 804 shares during the last quarter. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. Argus raised Kenvue to a “hold” rating in a report on Friday, March 6th. Canaccord Genuity Group lifted their target price on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a report on Wednesday, February 18th. Citigroup boosted their target price on shares of Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research report on Wednesday, February 18th. Jefferies Financial Group downgraded shares of Kenvue from a “buy” rating to a “hold” rating and decreased their price target for the company from $23.00 to $18.00 in a research note on Friday, January 30th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Kenvue in a research report on Friday, January 9th. Three investment analysts have rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $19.58.

Kenvue Price Performance

Kenvue stock opened at $17.52 on Friday. The firm has a market cap of $33.57 billion, a PE ratio of 22.75, a price-to-earnings-growth ratio of 3.98 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68. The stock’s fifty day moving average price is $18.01 and its two-hundred day moving average price is $17.13. Kenvue Inc. has a one year low of $14.02 and a one year high of $25.17.

Kenvue (NYSE:KVUE) last released its earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.22 by $0.05. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The firm had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $3.68 billion. During the same period in the prior year, the company posted $0.26 EPS. The company’s revenue was up 3.2% compared to the same quarter last year. As a group, research analysts expect that Kenvue Inc. will post 1.14 EPS for the current fiscal year.

Kenvue Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, February 25th. Shareholders of record on Wednesday, February 11th were paid a dividend of $0.2075 per share. This represents a $0.83 dividend on an annualized basis and a yield of 4.7%. The ex-dividend date was Wednesday, February 11th. Kenvue’s dividend payout ratio is presently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.